Good, balanced summary. Especially regarding the reporting style...

Good, balanced summary. Especially regarding the reporting style eoth pXRF assays for Hole 1 which I was critical of when announced and got quite a lot of shite thrown at me. You summed it up well in reminding that spot pXRF results for isolated copper sulphide blebs and veins can be easily misinterpreted in light of the mostly less mineralized drill core. Management did not try the same on reporting pXRF for Hole 2. As expected. Unfortunately many folk did not do "the interpretation" on that Hole 1 and I guess as Mr Market beletedly woke up the share price retreated rapidly leaving them high and dry. I baled on the Hole 1 announcement as soon as I saw how the announcement was reported. Might buy back in when things settle and the CR is out of the way